News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,292 Results
Type
Article (14264)
Company Profile (282)
Press Release (253746)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79594)
Career Advice (153)
Deals (13243)
Drug Delivery (35)
Drug Development (50484)
Employer Resources (31)
FDA (5727)
Job Trends (5136)
News (144540)
Policy (10042)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (2)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21689)
ALS (64)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (100)
Approvals (5756)
Artificial intelligence (123)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4561)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1478)
Cardiovascular disease (116)
Career advice (133)
Career pathing (2)
CAR-T (117)
Cell therapy (329)
Cervical cancer (8)
Clinical research (41097)
Collaboration (544)
Compensation (258)
Complete response letters (13)
COVID-19 (1034)
CRISPR (41)
C-suite (164)
Cystic fibrosis (76)
Data (1522)
Denatured (11)
Depression (30)
Diabetes (138)
Diagnostics (1302)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29832)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48622)
Executive appointments (460)
FDA (6426)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (96)
Generative AI (10)
Gene therapy (252)
GLP-1 (365)
Government (1081)
Grass and pollen (2)
Guidances (21)
Healthcare (6597)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (91)
Indications (20)
Infectious disease (1099)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7277)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (208)
Leadership (3)
Legal (1386)
Liver cancer (33)
Lung cancer (205)
Lymphoma (101)
Machine learning (3)
Management (7)
Manufacturing (139)
MASH (53)
Medical device (2608)
Medtech (2609)
Mergers & acquisitions (6299)
Metabolic disorders (389)
Multiple sclerosis (55)
NASH (13)
Neurodegenerative disease (69)
Neuropsychiatric disorders (25)
Neuroscience (1259)
NextGen: Class of 2025 (2018)
Non-profit (856)
Northern California (1706)
Now hiring (22)
Obesity (193)
Opinion (102)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (128)
Patient recruitment (76)
Peanut (35)
People (25678)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14511)
Phase II (19111)
Phase III (12094)
Pipeline (806)
Policy (44)
Postmarket research (853)
Preclinical (6139)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1422)
Recruiting (12)
Regulatory (8650)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1493)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1975)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (8)
The Weekly (36)
United States (13242)
Vaccines (213)
Venture capitalists (32)
Weight loss (109)
Women's health (15)
Worklife (2)
Date
Today (89)
Last 7 days (493)
Last 30 days (1533)
Last 365 days (19625)
2025 (6240)
2024 (20572)
2023 (22429)
2022 (26833)
2021 (27813)
2020 (23365)
2019 (16243)
2018 (11747)
2017 (13752)
2016 (11847)
2015 (14358)
2014 (10397)
2013 (7494)
2012 (7541)
2011 (7621)
2010 (7433)
Location
Africa (148)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (6)
Asia (17326)
Australia (2936)
California (3862)
Canada (1140)
China (360)
Colorado (149)
Connecticut (152)
Delaware (102)
Europe (37271)
Florida (465)
Georgia (115)
Idaho (16)
Illinois (231)
India (10)
Indiana (91)
Iowa (2)
Japan (74)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (475)
Massachusetts (3070)
Michigan (70)
Minnesota (144)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (962)
New Mexico (12)
New York (1040)
North Carolina (552)
North Dakota (5)
Northern California (1706)
Ohio (112)
Oklahoma (9)
Oregon (22)
Pennsylvania (740)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (4)
Southern California (1493)
Tennessee (25)
Texas (447)
Utah (53)
Virginia (78)
Washington D.C. (30)
Washington State (351)
Wisconsin (15)
268,292 Results for "gemini therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients
April 30, 2025
·
6 min read
Press Releases
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
March 17, 2025
·
7 min read
Press Releases
Ouster Launches Cloud Portal for Ouster Gemini Digital Lidar Perception Platform
March 18, 2025
·
5 min read
Press Releases
Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients
February 26, 2025
·
6 min read
Press Releases
Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients
January 21, 2025
·
6 min read
Press Releases
Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND
December 3, 2024
·
5 min read
Drug Development
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity.
June 24, 2024
·
9 min read
Press Releases
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
November 12, 2024
·
4 min read
Drug Development
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
AnaptysBio, Inc. announced positive top-line results from its global GEMINI-1 and GEMINI-2 Phase 3 trials evaluating the safety and efficacy of investigational imsidolimab in patients with generalized pustular psoriasis, a severe orphan disease that is potentially life-threatening if left untreated.
May 9, 2024
·
7 min read
Drug Development
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini.
March 4, 2024
·
5 min read
1 of 26,830
Next
